Clinical Trial Update: Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial in glioblastoma comparing dose-dense temozolomide after chemoradiation to temozolomide with all-trans retinoic acid; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioblastoma, Gliomas | Phase 2 | Status: COMPLETED | Results posted: 2018-03-07